Aurinia Pharmaceuticals
AUPH
#5227
Rank
S$1.60 B
Marketcap
$11.19
Share price
0.60%
Change (1 day)
5.33%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -S$57.36 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.20 Billion. In 2023 the company made an earning of -S$0.11 Billion, an increase over its 2022 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$57.36 Million-42.85%
2023 -S$0.11 Billion-31.8%
2022 -S$0.15 Billion-39.4%
2021 -S$0.25 Billion61.9%
2020 -S$0.15 Billion-9.73%
2019 -S$0.17 Billion92.85%
2018 -S$86.16 Million36.25%
2017 -S$63.24 Million106.29%
2016 -S$30.66 Million-15.4%
2015 -S$36.24 Million65.84%
2014 -S$21.85 Million129.82%
2013 -S$9.51 Million-26.6%
2012 -S$12.96 Million
2010 -S$7.34 Million-39.22%
2009 -S$12.07 Million-43.78%
2008 -S$21.47 Million-53.19%
2007 -S$45.85 Million42.97%
2006 -S$32.07 Million-23.03%
2005 -S$41.67 Million36.1%
2004 -S$30.62 Million172.57%
2003 -S$11.24 Million484.61%
2002 -S$1.93 Million
2000 -S$9.13 Million453.81%
1999 -S$1.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$6.67 B-11,682.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$7.37 Million-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$20.51 Million-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA